# Safety and Tolerability of SYNB1934 in Healthy Adult Volunteers

> **NCT04984525** · PHASE1 · COMPLETED · sponsor: **Synlogic** · enrollment: 106 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** SYNB1934
- **DRUG:** SYNB1618

## Key facts

- **NCT ID:** NCT04984525
- **Lead sponsor:** Synlogic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-02
- **Primary completion:** 2021-12-10
- **Final completion:** 2021-12-10
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2022-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04984525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04984525, "Safety and Tolerability of SYNB1934 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04984525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*